BioCentury
ARTICLE | Clinical News

Nepicastat: Completed Phase II enrollment

June 2, 2014 7:00 AM UTC

Biotie completed enrollment of 179 treatment-seeking cocaine-dependent patients in a double-blind, placebo-controlled, U.S. Phase II trial comparing 120 mg oral nepicastat once daily plus 100 mg oral ...